Novartis AG - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US66987V1098
121,00 € 0,00 (0,00%)
2026-06-04
DEL PRIS
SecurityDE:NOTA / Novartis AG - Depositary Receipt (Common Stock)
InstitutionBfsg, Llc
Latest Disclosed Ownership700 shares
Latest Disclosed Value $ 106,925
Bfsg, Llc reports 6.67% decrease in ownership of NOTA / Novartis AG - Depositary Receipt (Common Stock)

On April 28, 2026 - Bfsg, Llc filed a 13F-HR form disclosing ownership of 700 shares of Novartis AG - Depositary Receipt (Common Stock) (DE:NOTA) valued at $89,950 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 22, 2026 disclosing 750 shares of Novartis AG - Depositary Receipt (Common Stock). This represents a change in shares of -6.67% during the quarter. The current value of the position is $84,700 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-28 2026-03-31 13F NOVARTIS SPONSORED ADR 66987V109 700 -50 -6.67 107 2.91 0.0101
2026-01-22 2025-12-31 13F NOVARTIS SPONSORED ADR 66987V109 750 55 7.91 103 15.73 0.0100
2025-10-29 2025-09-30 13F NOVARTIS SPONSORED ADR 66987V109 695 9 1.31 89 7.23 0.0086
2025-07-15 2025-06-30 13F NOVARTIS SPONSORED ADR 66987V109 686 3 0.44 83 9.21 0.0093
2025-04-18 2025-03-31 13F NOVARTIS SPONSORED ADR 66987V109 683 13 1.94 76 16.92 0.0093
2025-01-31 2024-12-31 13F NOVARTIS SPONSORED ADR 66987V109 670 -330 -33.00 65 -43.48 0.0076
2024-10-16 2024-09-30 13F NOVARTIS SPONSORED ADR 66987V109 1,000 -12 -1.19 115 7.48 0.0134
2024-07-29 2024-06-30 13F NOVARTIS SPONSORED ADR 66987V109 1,012 10 1.00 108 11.46 0.0137
2024-04-23 2024-03-31 13F NOVARTIS SPONSORED ADR 66987V109 1,002 40 4.16 97 -1.03 0.0128
2024-04-23 2023-12-31 13F/A-1 NOVARTIS SPONSORED ADR 66987V109 962 962 97 0.0141
2024-02-02 2023-12-31 13F NOVARTIS SPONSORED ADR 66987V109 962 962 97 0.0141
2022-05-04 2022-03-31 13F NOVARTIS SPONSORED ADR 66987V109 0 -2,885 -100.00 0 -100.00
2022-01-24 2021-12-31 13F NOVARTIS SPONSORED ADR 66987V109 2,885 -1,055 -26.78 252 -21.74 0.0350
2021-11-03 2021-09-30 13F NOVARTIS SPONSORED ADR 66987V109 3,940 3,940 322 0.0492
2021-07-29 2021-06-30 13F NOVARTIS SPONSORED ADR 66987V109 0 -4,930 -100.00 0 -100.00
2021-04-26 2021-03-31 13F NOVARTIS SPONSORED ADR 66987V109 4,930 -3,090 -38.53 421 -44.39 0.0683
2021-01-26 2020-12-31 13F NOVARTIS SPONSORED ADR 66987V109 8,020 225 2.89 757 11.65 0.1256
2020-11-04 2020-09-30 13F NOVARTIS SPONSORED ADR 66987V109 7,795 820 11.76 678 11.33 0.1263
2020-07-22 2020-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 6,975 -330 -4.52 609 1.16 0.1313
2020-04-27 2020-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 7,305 -150 -2.01 602 -14.73 0.1545
2020-01-29 2019-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 7,455 -100 -1.32 706 7.79 0.1332
2019-10-25 2019-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 7,555 660 9.57 655 3.97 0.1452
2019-07-30 2019-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 6,895 1,337 24.06 630 17.98 0.2457
2019-04-18 2019-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 5,558 0 0.00 534 11.95 0.2000
2019-01-24 2018-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 5,558 -100 -1.77 477 -2.05 0.2166
2018-10-18 2018-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 5,658 -785 -12.18 487 0.00 0.2054
2018-07-31 2018-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 6,443 73 1.15 487 -5.44 0.2140
2018-05-07 2018-03-31 13F NOVARTIS A G SPONSORED ADR COM 66987V109 6,370 -100 -1.55 515 -5.16 0.2285
2018-01-23 2017-12-31 13F NOVARTIS A G SPONSORED ADR COM 66987V109 6,470 730 12.72 543 10.14 0.2292
2017-10-12 2017-09-30 13F NOVARTIS A G SPONSORED ADR COM 66987V109 5,740 425 8.00 493 11.04 0.2224
2017-08-10 2017-06-30 13F NOVARTIS A G SPONSORED ADR COM 66987V109 5,315 -220 -3.97 444 8.03 0.2182
2017-05-16 2017-03-31 13F Novartis A G Spon Adr COM 66987V109 5,535 5,535 411 0.2065
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.